<DOC>
	<DOC>NCT00926809</DOC>
	<brief_summary>This study will evaluate the effect of Helicobacter pylori eradication therapy on the healing of iatrogenic gastric ulcer caused by endoscopic mucosal resection of gastric neoplastic lesions and is a multicenter, randomized, double blind, and placebo controlled trial.</brief_summary>
	<brief_title>H. Pylori Eradication on Healing of Iatrogenic Gastric Ulcer by Endoscopic Mucosal Resection</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>30 75 years old Early gastric cancer (&lt; 3 cm in size, mucosa confined, differentiated type) or gastric adenoma (&lt; 3 cm in size) Helicobacter pylori positive Medication of antisecretory drugs (proton pump inhibitors, H2receptor antagonists, antacid, bismuth compound) History of Helicobacter pylori eradication History of gastric surgery or other cancers Major comorbidities Medication of ASA, NSAIDS, steroids, anticoagulants</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>endoscopic mucosal resection</keyword>
	<keyword>iatrogenic</keyword>
</DOC>